Skip to main content
. 2021 Nov 22;11:22636. doi: 10.1038/s41598-021-02168-4

Figure 2.

Figure 2

(a) The number of patients included in this study. Black solid lines represent the training with only UTokyo cohort, and blue solid lines represent the training with UTokyo cohort and a part of TCGA cohort. (b) The flow of patient-level prediction. Scale bar: 0.5 mm (UTokyo cohort), 2.5 mm (TCGA cohort). UTokyo- University of Tokyo, TCGA- The cancer genome atlas.